loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 207533 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 ARIPIPRAZOLE LAUROXIL (4)

filter

01 ALKERMES INC (4)

filter

01 SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR (4)

filter

01 1064MG/3.9ML (272.82MG/ML) (1)

02 441MG/1.6ML (275.63MG/ML) (1)

03 662MG/2.4ML (275.83MG/ML) (1)

04 882MG/3.2ML (275.63MG/ML) (1)

filter

01 USA (4)

URL Supplier Web Content
SUSPENSION, EXTENDED R...
882MG/3.2ML (275.63MG/...
ARISTADA
USA
207533
2015-10-05
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SUSPENSION, EXTENDED R...
441MG/1.6ML (275.63MG/...
ARISTADA
USA
207533
2015-10-05
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SUSPENSION, EXTENDED R...
1064MG/3.9ML (272.82MG...
ARISTADA
USA
207533
2017-06-05
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SUSPENSION, EXTENDED R...
662MG/2.4ML (275.83MG/...
ARISTADA
USA
207533
2015-10-05
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 207533

Looking for CTD TGA MCC DOSSIER APPLICATION 207533 4

19

Alkermes Plc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ARIPIPRAZOLE LAUROXIL, with a corresponding application number 207533 and regulatory information .

proudly manufactured in the

approval since 2015-10-05

Alkermes Plc's ARISTADA SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR, medication with 882MG/3.2ML (275.63MG/ML) of ARIPIPRAZOLE LAUROXIL.

18

Alkermes Plc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ARIPIPRAZOLE LAUROXIL, with a corresponding application number 207533 and regulatory information .

proudly manufactured in the

approval since 2015-10-05

Alkermes Plc's ARISTADA SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR, medication with 441MG/1.6ML (275.63MG/ML) of ARIPIPRAZOLE LAUROXIL.

17

Alkermes Plc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ARIPIPRAZOLE LAUROXIL, with a corresponding application number 207533 and regulatory information .

proudly manufactured in the

approval since 2017-06-05

Alkermes Plc's ARISTADA SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR, medication with 1064MG/3.9ML (272.82MG/ML) of ARIPIPRAZOLE LAUROXIL.

16

Alkermes Plc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ARIPIPRAZOLE LAUROXIL, with a corresponding application number 207533 and regulatory information .

proudly manufactured in the

approval since 2015-10-05

Alkermes Plc's ARISTADA SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR, medication with 662MG/2.4ML (275.83MG/ML) of ARIPIPRAZOLE LAUROXIL.

Post Enquiry
POST ENQUIRY